A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRI
Status:
Terminated
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety of GI-4000 and see what effects (good and
bad) it has against cancer over time. This study is also being done to measure the immune
response to GI-4000. Study drug will be given in addition to a standard of care which is a
standard therapy given to patients with your type of cancer (colon).